Target intelligence / Profile preview

LMX1B divergent transcript (LMX1B-DT)

Target
LMX1B-DT
Molecular classification
Other (lncRNA, long non-coding RNA)
01

Overview

LMX1B divergent transcript (LMX1B-DT) is a long non-coding RNA (lncRNA) gene located on chromosome 9 (chr9:126589327-126613761, hg38)[3][4]. It does not encode a functional protein and is categorized as an RNA gene of the lncRNA class[4]. LMX1B-DT is primarily noted for its genomic position relative to the protein-coding gene LMX1B, a transcription factor implicated in development and in conditions such as nail-patella syndrome[2][4]. There is currently no evidence indicating that LMX1B-DT serves as a therapeutic target, nor is there substantial functional or mechanistic information available regarding its specific role in human biology or disease[3][4]. Its relationship to disease is limited to its genomic linkage and not direct causative function. As such, it is not a receptor, enzyme, transporter, or recognized therapeutic target. Clarification: LMX1B-DT should not be confused with LMX1B, the protein-coding transcription factor important in development and disease (such as nail-patella syndrome)[2]. LMX1B-DT does not encode a protein, is not a receptor or drug target, and is not a well-studied regulatory RNA. This entry is likely inappropriate as a drug target, and the query may be based on confusion with LMX1B itself.

Other names
LMX1B divergent transcriptLMX1B-DT
02

Biological functions

Unknown
03

Disease associations

Nail-patella syndrome (by genomic location/association, not by causation or function)

Beyond the preview

Go deeper on LMX1B divergent transcript (LMX1B-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LMX1B divergent transcript (LMX1B-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call